Johnson & Johnson
Tracked across 7 events · 618 articles · First seen Feb 13, 2026 · Last active Apr 20, 2026
Live sentiment trends, attention charts, and prominence tracking available on the
NewsDesk Dashboard
Regulatory
Johnson & Johnson was found liable in a lawsuit alleging its talc-based baby powder caused ovarian cancer, resulting in a $250,000 award to Gayle Emerson's family. The company plans to appeal this verdict and faces over 67,000 similar lawsuits, which could lead to significant financial liabilities and reputational damage.
Feb 13, 2026 · 7 articles
Business
Johnson & Johnson is co-financing the clinical trials of bleximenib, an investigational oral menin inhibitor for acute myeloid leukemia, with Blackstone Life Sciences. This partnership leverages Johnson & Johnson's expertise in hematologic malignancies to address critical gaps in patient care.
Feb 23, 2026 · 7 articles
Business
Johnson & Johnson is a prominent company in the CAR T cell market, focusing on innovation and strategic initiatives to expand its presence.
Feb 16, 2026 · 7 articles
Regulatory
Johnson & Johnson (PTY) Ltd, a subsidiary of Johnson & Johnson, is under investigation by the South Africa===National Consumer Commission for its Stay Free brand sanitary pads. The findings of harmful chemicals could lead to significant regulatory actions and consumer distrust.
Feb 17, 2026 · 53 articles
Business
Johnson & Johnson is a partner in the development of ICOTYDE, with its subsidiary Johnson & Johnson===Janssen Pharmaceuticals holding the license. Protagonist Therapeutics' collaboration revenue includes milestones from the Johnson & Johnson agreement.
Feb 25, 2026 · 7 articles
+ 2 more events
View on Dashboard
Erik Haas
worldwide vice president of litigation
↔
Johnson & Johnson
Erik Haas is the worldwide vice president of litigation for Johnson & Johnson.
NEWSDESK
Track Johnson & Johnson live
Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.
Open Dashboard